Congress Questions FDA Objectivity on BPA

from USA Today

Congress is stepping in to ask questions about chemical industry influence in drafting a Food and Drug Administration report about the safety of a controversial chemical in baby bottles.

In August, the FDA declared the chemical, bisphenol A, or BPA, safe, a determination greeted skeptically by consumer groups who argue that hundreds of scientific studies suggest it may cause serious harm.

According to a letter to the FDA from Reps. John Dingell and Bart Stupak sent last week, the FDA hired a private consulting group with strong industry ties to perform some of its analyses of BPA.